Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2019C524 Product name: Galcanézumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2019C/524
Type:
Certificate
SPC type:
Medical
Basic patent number:
068092071
Status:
Withdrawn
Publication number:
2019C524
1rst applicant's nationality:
Procedural language:
French

Marketing authorization

Marketing authorization number:
EU/1/18/1330
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
16/11/2018
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
09/05/2019
First marketing authorization date:
16/11/2018
Grant date:
Activation date:
BE Publication date:
15/05/2019
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
02/11/2031
SPC/SPC Extension Expiration (if granted and all annual fees paid):
02/11/2031
Rejection date:
Withdrawal date:
08/12/2020

Applicant

Name:
Teva Pharmaceuticals International GmbH
Legal Form:
From:
15/05/2019
Address:
Schlüsselstrasse 12, 8645 Rapperswil-Jona, Switzerland (CH)
To:

Agent

Name:
KIRKPATRICK
Legal Form:
S.A.
From:
10/05/2019
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2019/15
Publication date:
13/06/2019
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
VRV
Journal edition number:
2020/30
Publication date:
10/02/2021
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
07/08/2019 Incoming Correspondence (Email) Cover letter 1 PDF /4/5/5/5/5/0721855554/docs/2019c524_0_incomingcorrespondenceelectronic_20190808_082038259.pdf
09/05/2019 General Document Other 8 PDF /4/5/5/5/5/0721855554/docs/2019c524_1_generaldocument_20190510_082354493.pdf
09/05/2019 Marketing Authorization 1st Marketing Authorization (EU) 3 PDF /4/5/5/5/5/0721855554/docs/2019c524_2_marketingauthorization_20190510_082448260.pdf
23/03/2023 Request For Change Letter and/or Form requesting a change in the Register 1 PDF /4/5/5/5/5/0721855554/docs/2019c524_3_rfc_20230404_085714217.pdf
15/05/2019 Publication I1 1 PDF /4/5/5/5/5/0721855554/docs/2019c524_4_i1document_20190515_135753591.pdf
09/05/2019 Abstract Product Characteristics Abstract of the characteristics of the product 63 PDF /4/5/5/5/5/0721855554/docs/2019c524_5_abstractproductcharacteristics_20190510_082419087.pdf
09/12/2020 Outgoing Correspondence 1 PDF /4/5/5/5/5/0721855554/docs/2019c524_6_outgoingcorrespondence_20201209_043428217.pdf
07/08/2019 General Document Other 3 PDF /4/5/5/5/5/0721855554/docs/2019c524_7_generaldocument_20190808_082037478.pdf
09/05/2019 General Document Other 3 PDF /4/5/5/5/5/0721855554/docs/2019c524_8_generaldocument_20190510_082418096.pdf
15/05/2019 Outgoing Correspondence 2 PDF /4/5/5/5/5/0721855554/docs/2019c524_9_outgoingcorrespondence_20190523_032734713.pdf
15/05/2019 Front Page 1 PDF /4/5/5/5/5/0721855554/docs/2019c524_10_i1frontpage_20190515_135752972.pdf
09/05/2019 Application Form 4 PDF /4/5/5/5/5/0721855554/docs/2019c524_11_applicationform_20190510_082450027.pdf